[
    {
        "S.No": "P1",
        "age": 30,
        "Sex": "M",
        "BMI": 24.2,
        "Co-Morbidity Conditions": "Hypothyroidism, Dyslipidemia",
        "Target BGL Range (mg/dL)": "80 - 180",
        "Avg.CHO/day(g)": 240,
        "Life Style": "Sedentary",
        "Oral Drugs": "Glycomet 250 mg",
        "TIR": 87.1,
        "Time Spent in Hypo": 5.4,
        "Time Spent in Hyper": 7.5,
        "TIR1": 63,
        "Time Spent in Hypo1": 8.6,
        "Time Spent in Hyper1": 27.6
    },
    {
        "S.No": "P2",
        "age": 60,
        "Sex": "F",
        "BMI": 23.6,
        "Co-Morbidity Conditions": "Hypothyroidism, Dyslipidemia, hypertension(HTN)",
        "Target BGL Range (mg/dL)": "80 - 150",
        "Avg.CHO/day(g)": 300,
        "Life Style": "Sedentary",
        "Oral Drugs": "Metadoze-1, Hepsodil-1, Victoza-1, Blisto-1/2",
        "TIR": 97,
        "Time Spent in Hypo": 0,
        "Time Spent in Hyper": 2.2,
        "TIR1": 53,
        "Time Spent in Hypo1": 8.32,
        "Time Spent in Hyper1": 38.2
    },
    {
        "S.No": "P3",
        "age": 36,
        "Sex": "F",
        "BMI": 32.4,
        "Co-Morbidity Conditions": "Dyslipidemia, HTN, kidney transplant",
        "Target BGL Range (mg/dL)": "80 - 140",
        "Avg.CHO/day(g)": 300,
        "Life Style": "Sedentary",
        "Oral Drugs": "Trajenta Duo 2.5/500, Metadose IPR",
        "TIR": 96,
        "Time Spent in Hypo": 3.7,
        "Time Spent in Hyper": 0,
        "TIR1": 82,
        "Time Spent in Hypo1": 17.4,
        "Time Spent in Hyper1": 0
    },
    {
        "S.No": "P4",
        "age": 59,
        "Sex": "M",
        "BMI": 25.7,
        "Co-Morbidity Conditions": "Liver problem",
        "Target BGL Range (mg/dL)": "80 - 180",
        "Avg.CHO/day(g)": 320,
        "Life Style": "Active",
        "Oral Drugs": "Glycomet, Metadoze"
    },
    {
        "S.No": "P5",
        "age": 63,
        "Sex": "M",
        "BMI": 27.5,
        "Co-Morbidity Conditions": "Dyslipidemia, Heart disease, CKD",
        "Target BGL Range (mg/dL)": "80 - 180",
        "Avg.CHO/day(g)": 240,
        "Life Style": "Sedentary",
        "Oral Drugs": "Glycomet, Glimepiride. Aplazar D-Rise, Metadoze. Carfer, Ril 25, Pre ganerve, Roliptin, Trajenta,clinipres"
    },
    {
        "S.No": "P6",
        "age": 72,
        "Sex": "M",
        "BMI": 25.1,
        "Co-Morbidity Conditions": "HEN, mild NPOR",
        "Target BGL Range (mg/dL)": "80 - 180",
        "Avg.CHO/day(g)": 280,
        "Life Style": "Active",
        "Oral Drugs": "Kombialyza 5/500 ,jardiance-25mg cetapin-500"
    },
    {
        "S.No": "P7",
        "age": 79,
        "Sex": "M",
        "BMI": 32.1,
        "Co-Morbidity Conditions": "CA sigmoid colon, CKD, HTN",
        "Target BGL Range (mg/dL)": "80 - 150",
        "Avg.CHO/day(g)": 220,
        "Life Style": "Active",
        "Oral Drugs": "Glycomet 300mg ,metadoze"
    },
    {
        "S.No": "P8",
        "age": 80,
        "Sex": "F",
        "BMI": 31.9,
        "Co-Morbidity Conditions": "CKD, Hypertention",
        "Target BGL Range (mg/dL)": "80 - 180",
        "Avg.CHO/day(g)": 20,
        "Life Style": "Sedentary",
        "Oral Drugs": "GP-0.5,Metadose"
    },
    {
        "S.No": "P9",
        "age": 58,
        "Sex": "F",
        "BMI": 23.1,
        "Co-Morbidity Conditions": "Hypothyroidism, Dyslipidemia",
        "Target BGL Range (mg/dL)": "70 - 180",
        "Avg.CHO/day(g)": 300,
        "Life Style": "Sedentary",
        "Oral Drugs": "Metadose-1,Roliptin"
    },
    {
        "S.No": "P10",
        "age": 55,
        "Sex": "M",
        "BMI": 23.2,
        "Co-Morbidity Conditions": "Dyslipidemia CKD",
        "Target BGL Range (mg/dL)": "80 - 180",
        "Avg.CHO/day(g)": 234,
        "Life Style": "Sedentary",
        "Oral Drugs": "Metafort 500 mg, Victoza injection"
    },
    {
        "S.No": "P11",
        "age": 57,
        "Sex": "M",
        "BMI": 30.1,
        "Co-Morbidity Conditions": "Hypothyroidism, Dyslipidemia",
        "Target BGL Range (mg/dL)": "80 - 180",
        "Avg.CHO/day(g)": 270,
        "Life Style": "Active",
        "Oral Drugs": "Diafer 250, Jerdiance 100 mg"
    },
    {
        "S.No": "P12",
        "age": 66,
        "Sex": "F",
        "BMI": 30.8,
        "Co-Morbidity Conditions": "Hypothyroidism, Dyslipidemia",
        "Target BGL Range (mg/dL)": "80 - 140",
        "Avg.CHO/day(g)": 300,
        "Life Style": "Active",
        "Oral Drugs": "Metafort 1000 mg. Gride 1 mg, Vic-toza injection"
    },
    {
        "S.No": "P13",
        "age": 70,
        "Sex": "F",
        "BMI": 24.7,
        "Co-Morbidity Conditions": "HTN, Coronary artery bypass graft surgery (CABG)",
        "Target BGL Range (mg/dL)": "90 - 180",
        "Avg.CHO/day(g)": 280,
        "Life Style": "Sedentary",
        "Oral Drugs": "T-Semi-Amary 0.5, PPG Mei 0.2"
    },
    {
        "S.No": "P14",
        "age": 65,
        "Sex": "F",
        "BMI": 34.5,
        "Co-Morbidity Conditions": "Dyslipidemia, HIN, Anemia, CABG",
        "Target BGL Range (mg/dL)": "80 - 140",
        "Avg.CHO/day(g)": 320,
        "Life Style": "Sedentary",
        "Oral Drugs": "Diafer 250"
    },
    {
        "S.No": "P15",
        "age": 62,
        "Sex": "F",
        "BMI": 29.1,
        "Co-Morbidity Conditions": "CKD,HTN",
        "Target BGL Range (mg/dL)": "90 - 180",
        "Avg.CHO/day(g)": 250,
        "Life Style": "Sedentary",
        "Oral Drugs": "T-semi-Army1 0.5 mg"
    }
]